triazoles has been researched along with Brill-Symmers Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboukameel, A; Al-Katib, A; Azmi, AS; Kauffman, M; McCauley, D; Mohammad, RM; Shacham, S | 1 |
| de La Tour, R; Lacroix, C; Lagrange-Xélot, M; Molina, JM; Schlemmer, F; Socié, G | 1 |
| Bernstein, SH; Burack, WR; Cochran, MR; Hilchey, SP; Hyrien, O; Kobie, JJ; Mosmann, TR; Quataert, SA; Secor-Socha, S; Wang, JC | 1 |
3 other study(ies) available for triazoles and Brill-Symmers Disease
| Article | Year |
|---|---|
Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas.
Topics: Acrylates; Active Transport, Cell Nucleus; Animals; Exportin 1 Protein; Humans; Karyopherins; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mice; Mice, SCID; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Triazoles; Tumor Cells, Cultured; Waldenstrom Macroglobulinemia; Xenograft Model Antitumor Assays | 2013 |
Breakthrough Rhizopus infection on posaconazole prophylaxis following allogeneic stem cell transplantation.
Topics: Antifungal Agents; Humans; Lymphoma, Follicular; Male; Middle Aged; Mucormycosis; Rhinitis; Rhizopus; Sinusitis; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Triazoles | 2008 |
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
Topics: Adenosine; Adenosine Triphosphate; Antigens, CD; Apyrase; CD8-Positive T-Lymphocytes; Clonal Anergy; Humans; Interferon-gamma; Interleukin-2; Lymphocytes, Tumor-Infiltrating; Lymphoma, Follicular; Neuroprotective Agents; Pyrimidines; Receptors, Purinergic P1; T-Lymphocytes, Regulatory; Triazines; Triazoles | 2009 |